Shaymaa Essam El Feky (Shaymaa E El Feky)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Breast Cancer Cells

Hyaluronic Acid

Top Venues

Medical oncology (Northwood, London, England)

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Shaymaa Essam El Feky, Karen Adel Fakhry, Amr M Hussain, Fawziya A R Ibrahim, Mohamed Ibrahim Morsi
MLKL regulates radiation-induced death in breast cancer cells: an interplay between apoptotic and necroptotic signals. Medical oncology (Northwood, London, England) 41 (7) (2024)
Shaymaa Essam El Feky, Karen Adel Fakhry, Amr M Hussain, Fawziya A R Ibrahim, Mohamed Ibrahim Morsi
MLKL regulates radiation-induced death in breast cancer cells: an interplay between apoptotic and necroptotic signals. Medical oncology (Northwood, London, England) 41 (7) (2024)
Shaymaa Essam El Feky, Karen Adel Fakhry, Amr M Hussain, Fawziya A R Ibrahim, Mohamed Ibrahim Morsi
MLKL regulates radiation-induced death in breast cancer cells: an interplay between apoptotic and necroptotic signals. Medical oncology (Northwood, London, England) 41 (7) (2024)
Karim Abdelazim, Amr Ghit, Dina Assal, Neamat Dorra, Nehad Noby, Sherine N Khattab, Shaymaa Essam El Feky, Ahmed Hussein
Production and therapeutic use of astaxanthin in the nanotechnology era. Pharmacological reports : PR (2023)
Karim Abdelazim, Amr Ghit, Dina Assal, Neamat Dorra, Nehad Noby, Sherine N Khattab, Shaymaa Essam El Feky, Ahmed Hussein
Correction: Production and therapeutic use of astaxanthin in the nanotechnology era. Pharmacological reports : PR (2023)
Karim Abdelazim, Amr Ghit, Dina Assal, Neamat Dorra, Nehad Noby, Sherine N Khattab, Shaymaa Essam El Feky, Ahmed Hussein
Production and therapeutic use of astaxanthin in the nanotechnology era. Pharmacological reports : PR (2023)